Phase I Study of MEM-288 Oncolytic Virus in Solid Tumors including Non-Small Cell Lung Cancer (NSCLC)

Clinical Trial Grant

Duke Scholars

Principal Investigator Neal Edward Ready Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Memgen, Inc

Start Date

January 6, 2022

End Date

December 30, 2026

Administered By

Duke Cancer Institute

Awarded By

Memgen, Inc

Start Date

January 6, 2022

End Date

December 30, 2026